Notable Downgrades: ResMed Inc. (RMD), Dish Network (DISH), Zillow Group (Z), Exar Corp. (EXAR), GlaxoSmithKline (GSK)

Analysts at BofA/Merrill (BAC) downgraded ResMed Inc. (RMD) from ‘Buy‘ to ‘Neutral‘ in a research report issued to clients on Wednesday. On valuation measures, ResMed Inc. stock it’s trading at a forward P/E multiple of 19.93x, and at a multiple of 22.36x this year’s estimated earnings. The t-12-month revenue at ResMed Inc. is $1.64 billion. […] View the full post at: Notable Downgrades: ResMed Inc. (RMD), Dish Network (DISH), Zillow Group (Z), Exar Corp. (EXAR), GlaxoSmithKline (GSK) Related posts: Barclays Downgrades GE Unit Debt Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock Moody’s Downgrades Greece’s Debt Rating to A2